What is he best known for?
The fields of study he is best known for:
Daniel J. Weisenberger focuses on Cancer research, DNA methylation, Genetics, Gene and microRNA.
The study incorporates disciplines such as KRAS, CDKN2A, Transcriptome and Adenocarcinoma in addition to Cancer research.
His DNA methylation research includes elements of Serous fluid, Microsatellite instability, IDH1, Glioma and Exome.
His Microsatellite instability study combines topics in areas such as Colorectal cancer and MLH1.
Within one scientific family, he focuses on topics pertaining to PBRM1 under microRNA, and may sometimes address concerns connected to Signal transduction, Chromatin and SETD2.
As a part of the same scientific family, Daniel J. Weisenberger mostly works in the field of MicroRNA sequencing, focusing on Exome sequencing and, on occasion, Cancer.
His most cited work include:
- Comprehensive molecular portraits of human breast tumours (7253 citations)
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways (5484 citations)
- Comprehensive molecular characterization of human colon and rectal cancer (5012 citations)
What are the main themes of his work throughout his whole career to date?
Daniel J. Weisenberger mainly investigates DNA methylation, Cancer research, Methylation, Epigenetics and Genetics.
His DNA methylation study is focused on Gene in general.
His work carried out in the field of Cancer research brings together such families of science as MLH1, Microsatellite instability, Chromatin, microRNA and Colorectal cancer.
His MLH1 research incorporates themes from Germline mutation and Lynch syndrome.
Oncology, Pathology and Immunology is closely connected to Cancer in his research, which is encompassed under the umbrella topic of Methylation.
His Epigenetics research focuses on Epigenomics and how it connects with RNA-Directed DNA Methylation.
He most often published in these fields:
- DNA methylation (62.43%)
- Cancer research (38.12%)
- Methylation (24.86%)
What were the highlights of his more recent work (between 2016-2021)?
- DNA methylation (62.43%)
- Cancer research (38.12%)
- Epigenetics (23.76%)
In recent papers he was focusing on the following fields of study:
Daniel J. Weisenberger mostly deals with DNA methylation, Cancer research, Epigenetics, Internal medicine and Oncology.
His DNA methylation research integrates issues from Carcinogenesis, Methylation and Cell biology.
Daniel J. Weisenberger interconnects Oncogene, Regulation of gene expression, microRNA, Gene and DNA Methyltransferase Inhibitor in the investigation of issues within Cancer research.
His Gene study incorporates themes from Transforming growth factor beta and Signal transduction.
The Epigenetics study combines topics in areas such as Bladder cancer, Corneal endothelium, Promoter, Epigenomics and Epigenome.
Daniel J. Weisenberger combines subjects such as Left colon, Oxaliplatin, Colon tissue and Adenocarcinoma with his study of Oncology.
Between 2016 and 2021, his most popular works were:
- Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma (805 citations)
- Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma (647 citations)
- Pan-cancer analysis of whole genomes (538 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Cancer research, microRNA, Genomics, DNA methylation and Oncogene.
His research in Cancer research intersects with topics in Thymic carcinoma, KRAS and Transcription factor, Gene.
Daniel J. Weisenberger has included themes like Liver cancer and Hepatocellular carcinoma in his Gene study.
His work deals with themes such as PBRM1, CDKN2A, GNAS complex locus and ARID1A, which intersect with microRNA.
His Genomics research is multidisciplinary, incorporating elements of Somatic cell, Mutation, Whole genome sequencing, Germline and Massive parallel sequencing.
Daniel J. Weisenberger performs multidisciplinary study in DNA methylation and Undifferentiated Pleomorphic Sarcoma in his work.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
